Chung-Ang University Researchers Develop Novel DNA Biosensor for Early Diagnosis of Cervical Cancer

Chung-Ang University Researchers Develop Novel DNA Biosensor for Early Diagnosis of Cervical Cancer

Molybdenum disulfide (MoS2) has recently garnered attention among materials science researchers owing to its ability to form two-dimensional nanosheets like graphene. The nanosheets are created by the stacking of S–Mo–S layers interacting via Van der Waals interactions. Additionally, the unique structural, optical, thermal, and electrochemical properties of MoS2 have opened up multiple research avenues across several fields, including the development of biomolecule sensing and chemical detection platforms, optoelectronics, supercapacitors, and batteries.

Traditionally, carbon nanostructures have been employed as an immobilization platform for DNA. In order to substitute carbon with MoS2 as an effective electrochemical DNA sensor, the electrical conductivity of MoS2 needs to be improved considerably. Against this backdrop, Associate Professor Eunah Kang and Mr. Youngjun Kim from the School of Chemical Engineering and Material Science at Chung-Ang University, Korea have recently come up with an elegant solution. The duo has developed an electrochemical DNA biosensor using a graphitic nano-onion/molybdenum disulfide (MoS2) nanosheet composite, which effectively detects human papillomavirus (HPV)-16 and HPV-18, and can serve as an early diagnosis of cervical cancer.

“Nano-onions possess graphitic sp2 structures and are derived from crystalline sp3 nanodiamonds via thermal annealing or laser irradiation,” explains Dr. Kang. Their breakthrough was published in Volume 21 of the Journal of Nanobiotechnology on 10 June 2023.

The researcher duo prepared the novel electrode surface for probing DNA chemisorption by enabling chemical conjugation between two functional groups: acyl bonds on the surfaces of functionalized nano-onions and amine groups present on the modified MoS2 nanosheets. Cyclic voltammetry experiments revealed that a 1:1 composite electrode had an improved rectangular shape compared to that of an MoS2 nanosheet electrode. “This indicated the amorphous nature of the nano-onions with curved carbon layers that facilitated an enhancement in electronic conductivity compared to MoS2 nanosheet alone,” highlights Dr. Kang.

Additionally, the duo measured the sensitivity of their novel electrochemical DNA biosensor device towards HPV-16 and HPV-18 by employing differential pulse voltammetry (DPV) technique in the presence of methylene blue (MB) as a redox indicator. Dr. Kang elaborates: “The DPV current peak was lowered after probe DNA chemisorption and target DNA hybridization. Since the hybridized DNA was double-stranded, it induced less effective MB electrostatic intercalation, resulting in a lower oxidation peak.”

The duo found that, compared to the MoS2 nanosheet electrode, the nano-onion/MoS2 nanosheet composite electrode attained higher current peaks, indicating a greater change in the differential peak. This was attributed to an enhanced conductive electron transfer owing to the nano-onion.

Notably, the target DNAs produced from HPV-16 and HPV-18 Siha and Hela cancer cell lines were detected by the proposed sensor effectively and with high specificity. Consequently, MoS2 nanosheets with improved electrical conductivity facilitated by complexation with nano-onions provides a suitable platform for developing effective and efficient electrochemical biosensors for the early diagnosis of a wide variety of ailments, including cervical cancer.

Furthermore, combining nano-onions or nanodiamonds with different organic biomaterials can facilitate chemical functionality, electron transfer conductivity, light absorption, and more. These, in turn, can lead to innovative disease sensing, targeted drug delivery systems, and biomedical imaging and diagnostics.

Reference

Title of original paper: A graphitic nano-onion/molybdenum disulfide nanosheet composite as a platform for HPV-associated cancer-detecting DNA biosensors

Journal: Journal of Nanobiotechnology

DOI: https://doi.org/10.1186/s12951-023-01948-6

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Thermo Scientific™ Dionex™ Inuvion™ Ion Chromatography (IC) system, helping to make ion analysis simpler and more intuitive for labs of all sizes. The new analytical instrument is designed to be easily reconfigurable, providing those who require determination of ionic and small polar compounds with a one stop shop for consistent, reliable ion analysis.
This new collaboration is another example of Blacksmith's creative deal-making with top tier partners that bring expertise to the table which helps de-risk and accelerate scientific discoveries for the development of valuable products.
Heparin Sodium 2,000 units in 0.9% Sodium Chloride Injection 1,000 mL (2 units/mL), is indicated as an anticoagulant to maintain catheter patency.
Through this agreement, RaySearch acquires full ownership of all rights to the product DrugLog for its application in the field of oncology, including the measuring device, calibration parameters, source code, as well as intellectual property rights.
Anna Kazanchyan, MD, Founder and CEO of Saghmos Therapeutics. "We are very pleased to announce the Notice of Allowance for our second patent, which will enhance the long-term value of ST-62516. Saghmos continues to build its intellectual property estate."

By using this website you agree to accept Medical Device News Magazine Privacy Policy